Avid Logo June 2022.jpg
Avid Bioservices to Participate in the Credit Suisse 31st Annual Healthcare Conference
November 02, 2022 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Logo June 2022.jpg
Avid Bioservices to Participate in RBC Global CDMO Conference
September 27, 2022 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Logo June 2022.jpg
Avid Bioservices Appoints Michael Alston, Jr. as Vice President, Operations
September 22, 2022 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
AMR Logo.png
Global Atopic Dermatitis Market to Reach $22.6 Billion by 2031: Allied Market Research
September 13, 2022 20:00 ET | Allied Market Research
Portland, OR, Sept. 13, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Atopic Dermatitis Market generated $5.3 billion in 2021, and is projected to...
Avid Logo June 2022.jpg
Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2022 and Recent Developments
September 06, 2022 16:05 ET | Avid Bioservices, Inc
-- Recorded First Quarter Revenue of $36.7 Million -- -- Signed $41 Million in Net New Business Orders and Ended the Quarter with a Record High Backlog of $157 Million -- -- Facilities and...
Logo padrão.png
Biotimize Announces the Opening of a Fundraising Round to Build the First Biological CDMO in Brazil
September 05, 2022 08:30 ET | Biotimize - Biotechnology as a Service
PIRACICABA, Brazil, Sept. 05, 2022 (GLOBE NEWSWIRE) -- Biotimize, a functional growth-stage biotechnology as a service (BaaS) company with a mission to transform lives through biotechnology, today...
Avid Logo June 2022.jpg
Avid Bioservices Appoints Pramthesh (Prem) Patel, Ph.D., as Vice President, Process Development for Mammalian Cell Business
September 01, 2022 08:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Sept. 01, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Logo June 2022.jpg
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2023 After Market Close on September 6, 2022
August 30, 2022 16:05 ET | Avid Bioservices, Inc
TUSTIN, Calif., Aug. 30, 2022 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Emery Pharma Logo
Emery Pharma Announces New Biologics Analytical Division
August 17, 2022 08:00 ET | Emery Pharma
ALAMEDA, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Emery Pharma has officially expanded its state-of-the-art laboratories which feature a brand-new High-Resolution Orbitrap Mass Spectrometer,...
TIP_link_300x300.jpg
Lyophilized Injectable Market Share to hit $4Bn, Globally by 2028 Growing at 5.8% CAGR | Exclusive Report by The Insight Partners
August 11, 2022 05:22 ET | The Insight Partners
New York, Aug. 11, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Lyophilized Injectable Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type of...